Ikarian Capital’s Chemomab Therapeutics CMMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$81.3K Hold
51,793
0.01% 151
2025
Q4
$85.5K Sell
51,793
-1,469
-3% -$3.9K 0.01% 164
2025
Q3
$140K Sell
53,262
-1
-0% -$4 0.01% 157
2025
Q2
$247K Hold
53,263
0.05% 106
2025
Q1
$232K Hold
53,263
0.03% 134
2024
Q4
$386K Sell
53,263
-85
-0.2% -$537 0.05% 136
2024
Q3
$335K Hold
53,348
0.05% 125
2024
Q2
$196K Hold
53,348
0.03% 106
2024
Q1
$166K Hold
53,348
0.02% 128
2023
Q4
$109K Hold
53,348
0.01% 126
2023
Q3
$191K Hold
53,348
0.02% 123
2023
Q2
$280K Sell
53,348
-5,829
-10% -$36.8K 0.04% 107
2023
Q1
$342K Sell
59,177
-19,171
-24% -$150K 0.08% 100
2022
Q4
$1M Buy
78,348
+16,874
+27% +$146K 0.24% 51
2022
Q3
$612K Sell
61,474
-5,552
-8% -$71.5K 0.12% 77
2022
Q2
$992K Hold
67,026
0.18% 76
2022
Q1
$1.29M Buy
67,026
+710
+1% +$14K 0.17% 88
2021
Q4
$1.83M Sell
66,316
-5,000
-7% -$177K 0.27% 70
2021
Q3
$3.16M Sell
71,316
-1,318
-2% -$80.2K 0.22% 101
2021
Q2
$5.53M Buy
+72,634
New +$7.1M 0.45% 62

Other funds holding CMMB